FDA Inspection
Scranton Equity ExchangeScranton Equity Exchange – FDA Inspection, May 21, 2024
Record Details
This FDA Inspection record concerns Scranton Equity Exchange, with an inspection on May 21, 2024, issued by the Minneapolis District Office, covering animal drugs & feeds.
- Company
- Scranton Equity Exchange
- Inspection Date
- May 21, 2024
- Product Type
- Animal Drugs & Feeds
View Company Profile
ID · 916207f0-d85d-493a-8d6c-f86ab8cbdf7a
Inspection Facts
- Inspection number
- 1239921
- FDA center
- Animal Drugs & Feeds
- Outcome
- Form 483 issued
Other FDA inspections of Scranton Equity Exchange
5| Date | Classification | Office | Project area |
|---|---|---|---|
| July 10, 2019 | Not classified | Minneapolis District Office | |
| June 5, 2018 | Not classified | Minneapolis District Office | |
| June 5, 2013 | NAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
| April 24, 2012 | NAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
| May 27, 2010 | NAI | Center for Veterinary Medicine | Monitoring of Marketed Animal Drugs, Feed, and Devices |
Other documents for Scranton Equity Exchange
- FDA Inspection 1096757 - 2019-07-10
- FDA Inspection 1055531 - 2018-06-05
- FDA Inspection 836260 - 2013-06-05
- FDA Inspection 791637 - 2012-04-24
- FDA Inspection 667335 - 2010-05-27
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.